Variable | Patients who died in 30 days | Patients who survived | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|---|---|
n = 46 | n = 314 | OR (95% CI) | P value | AOR (95% CI) | P value | |
Age, mean (SD), years | 74.8 (16.3) | 63.1 (19.9) | 1.04 (1.02-1.06) | <0.001a | 1.04 (1.02-1.06) | <0.001 |
Male, no (%) | 31 (67.4) | 186 (59.2) | 1.42 (0.74-2.74) | 0.29 | ||
Residence in LTCF, no (%) | 18 (39.1) | 56 (17.8) | 2.96 (1.53-5.72) | 0.001a | ||
Charlson co-morbidity index, mean (SD) | 3.5 (2.2) | 2.6 (2.4) | 1.15 (1.02-1.30) | 0.018a | ||
Acquisition-healthcare associated, no (%) | 35 (76.1) | 185 (58.9) | 2.22 (1.09-4.53) | 0.029a | ||
Underlying immunosuppression, no (%) | 14 (30.4) | 98 (31.2) | 0.96 (0.49-1.89) | 0.92 | ||
High risk BSI sourcesb, no (%) | 30 (65.2) | 153 (48.7) | 1.97 (1.03-3.76) | 0.039a | 2.30 (1.16-4.57) | 0.02 |
Pitt bacteraemia score, median (IQR) | 2 (1-4) | 1 (0-2) | 1.39 (1.18-1.64) | <0.001a | 1.36 (1.15-1.61) | <0.001 |
Severe sepsis or septic shock, no (%) | 13 (28.3) | 38(12.1) | 2.86 (1.39-5.91) | 0.005c | ||
ICU admission, no (%) | 12 (26.1) | 51 (16.2) | 1.82 (0.88-3.75) | 0.11 | ||
Bacteraemia due to MDR organisms, no (%) | 28 (60.9) | 152 (48.4) | 1.66 (0.88-3.12) | 0.12 | ||
Inactive empiric antibiotic, no (%) | 16 (34.8) | 61 (19.4) | 2.21 (1.13-4.31) | 0.02a |